Mindpeak vs Proscia
One of these scores the slide and the other manages the slides, which makes them complementary more often than competitive. Mindpeak quantifies biomarkers, with eleven European marked algorithms covering breast markers and lung immunotherapy scoring, independent published evidence and distribution through partner platforms as well as directly. Proscia is the platform, managing and analysing whole slide data for clinical laboratories and life sciences customers, with the deeper Western installed base. A laboratory trying to make its immunohistochemistry scoring reproducible across pathologists wants Mindpeak; one trying to go digital at all wants Proscia, and will then need algorithms to run on it. The variable neither publishes is the one that matters most for quantitative scoring: how the model performs on tissue prepared and scanned differently from its training set.
- Biomarker quantification across eleven European marked algorithms covering the highest volume immunohistochemistry workload, rather than cancer detection alone.
- Genuinely independent published evidence exists, and the technical claim about its breast immunohistochemistry model is specific and checkable.
- Distribution runs through partner platforms as well as direct sale, so a laboratory already running one can adopt the algorithms without a separate integration.
- The platform manages and analyses whole slide data for clinical laboratories and life sciences customers at established scale, with the deeper Western installed base.
- Serving both diagnostic work and research contracts on the same infrastructure spreads the investment across two budgets.
- For a laboratory in North America or Europe, an established platform with local support and regulatory standing is the lower risk deployment.
Side by Side
| Axis | M Mindpeak |
P Proscia |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Digital Pathology AI page.
These sit at different layers and a laboratory may well run both, since one supplies scoring algorithms and the other supplies the platform they can run on. Mindpeak publishes no information security management certification and no health privacy position. Neither publishes pricing.
Staining and scanner variation between laboratories is the largest uncontrolled variable for quantitative immunohistochemistry in particular, because the score depends on preparation before it depends on the model, and neither vendor publishes performance across that variation.